Entrada Therapeutics Inc (TRDA)
NASDAQ
The current TRDA market cap is 724.82M. The company's latest EPS is USD -0.1786 and P/E is -108.51.
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | |||
Total Revenue | 25.26M | 18.17M | 43.74M | 41.85M | 59.12M |
Operating Income | -5.78M | -16.3M | 14.01M | 4.91M | 21.11M |
Net Income | -6.67M | -25.93M | 35.46M | -9.54M | 23.5M |
Year End December 30 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 129.01M |
Operating Income | -51.13M | -97.25M | -3.16M |
Net Income | -51.16M | -94.62M | -6.69M |
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | |||
Total Assets | 475.57M | 493.98M | 485.03M | 469.19M | 510.84M |
Total Liabilities | 245.96M | 287.08M | 238.37M | 226.83M | 241.48M |
Total Equity | 229.61M | 206.91M | 246.66M | 242.36M | 269.37M |
Year End December 30 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
USD ($) | USD ($) | USD ($) | |
Total Assets | 305.83M | 252.06M | 469.19M |
Total Liabilities | 7.12M | 39.5M | 226.83M |
Total Equity | 298.72M | 212.55M | 242.36M |
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | |||
Operating | 203.4M | 168.31M | 143.82M | 139.8M | -25.52M |
Investing | -40.44M | -153.7M | -157.44M | -138.4M | 26.15M |
Financing | 19.54M | 19.98M | 20.35M | 21.04M | 206k |
Year End December 30 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
USD ($) | USD ($) | USD ($) | |
Operating | -50.86M | -93.79M | 139.8M |
Investing | -4.58M | -148.65M | -138.4M |
Financing | 307.46M | 479k | 21.04M |
Market Cap | 724.82M |
Price to Earnings Ratio | -108.51 |
Price to Sales Ratio | 5.62 |
Price to Cash Ratio | 10.73 |
Price to Book Ratio | 2.99 |
Dividend Yield | - |
Shares Outstanding | 37.42M |
Average Volume (1 week) | 90.09k |
Average Volume (1 Month) | 136.35k |
52 Week Change | 68.29% |
52 Week High | 20.49 |
52 Week Low | 11.05 |
Spread (Intraday) | 19.95 (72.02%) |
Company Name | Entrada Therapeutics Inc |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://www.entradatx.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.